CRISPR: The Gene Editing Revolution | Frenly Widget

CRISPR, or Clustered Regularly Interspaced Short Palindromic Repeats, is a gene editing tool that has revolutionized the field of biotechnology. First discovered in 2012 by scientists Jennifer Doudna and Emmanuelle Charpentier, CRISPR allows for precise editing of DNA sequences, enabling scientists to modify genes with unprecedented accuracy. With a vibe score of 8, CRISPR has sparked intense debate and discussion, with proponents arguing that it holds the key to curing genetic diseases and opponents raising concerns about its potential misuse. As of 2022, CRISPR has been used in various applications, including treating sickle cell anemia and muscular dystrophy, with over 1,000 clinical trials currently underway. Despite the controversy, CRISPR has been widely adopted, with companies like Editas Medicine and CRISPR Therapeutics leading the charge. As the technology continues to evolve, it's estimated that the global CRISPR market will reach $10 billion by 2025, with the potential to impact over 10,000 genetic diseases.